YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors.
about
DNA repair targeted therapy: The past or future of cancer treatment?Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.
P2860
YU238259 Is a Novel Inhibitor of Homology-Dependent DNA Repair That Exhibits Synthetic Lethality and Radiosensitization in Repair-Deficient Tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
YU238259 Is a Novel Inhibitor ...... on in Repair-Deficient Tumors.
@ast
YU238259 Is a Novel Inhibitor ...... on in Repair-Deficient Tumors.
@en
type
label
YU238259 Is a Novel Inhibitor ...... on in Repair-Deficient Tumors.
@ast
YU238259 Is a Novel Inhibitor ...... on in Repair-Deficient Tumors.
@en
prefLabel
YU238259 Is a Novel Inhibitor ...... on in Repair-Deficient Tumors.
@ast
YU238259 Is a Novel Inhibitor ...... on in Repair-Deficient Tumors.
@en
P2093
P2860
P1476
YU238259 Is a Novel Inhibitor ...... ion in Repair-Deficient Tumors
@en
P2093
Denton Hoyer
Elizabeth Peterson-Roth
Gregory C Stachelek
Jack M Qian
Janie Merkel
Laura Abriola
Luke R G Pike
Rafael J Fernandez
William Hungerford
Yanfeng Liu
P2860
P304
P356
10.1158/1541-7786.MCR-15-0036
P577
2015-06-26T00:00:00Z